EUVIMEDEUVIMED entdecken
Crossref

Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico

José María Mostaza, Carlos Lahoz, Miguel A Salinero-Fort, Eva Estirado, Francisca García-Iglesias, Teresa González Alegre, Víctor Cornejo, en representación de los investigadores del estudio ESPREDIA

Medicina Clínica · 2025

DOI: 10.1016/j.medcli.2025.106987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2025. Verfasst von José María Mostaza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Lípidos y Riesgo Cardiovascular, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, España. Electronic address: josemaria.mo…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardiovascular Diseases, Vascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Novo Nordisk Pharma Co Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most vascular complications occur in persons with a low or moderate calculated vascular risk. We have evaluated the added prediction of the metabolic syndrome (MS) to the presence of subclinical vascular disease (SVD), beyond that estimated by the cardiovascular risk calculation. PATIENTS AND METHODS: Cross-sectional population-based study, in 1,061 subjects aged 45 to 75 years, without diabetes or known vascular disease, randomly selected from the Primary Care registries of Madrid (Spain). Vascular risk was calculated using SCORE2 and SCORE2-OP, the presence of MS was determined, and the prevalence of SVD was established by quantification of carotid plaques and ankle-brachial index. RESULTS: Of the included population, 40.2% was at low/moderate risk, 54.5% at high risk and 5.3% at very high risk. A total of 36.1% met the criteria for MS. The prevalence of SVD was 27.7, 50.1 and 71.4% in subjects at low/moderate, high and very high risk without MS, and 42.5, 62.6 and 78.6% if they had MS, respectively. The association of MS with the presence of EVS was independent of its separate components. A total of 23.1% of the participants were receiving statin treatment. Statin use was independent of the calculated cardiovascular risk and much higher in subjects with MS (38.6 vs. 12.8%). CONCLUSION: Subjects with MS have a high prevalence of SVD, independent of the estimated risk. The use of statins is more prevalent in subjects with the MS, and is independent of the estimated cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardiovascular DiseasesVascular DiseasesHumansMaleAgedFemaleCross-Sectional StudiesMiddle AgedPrevalenceSpainHeart Disease Risk FactorsRisk AssessmentAnkle Brachial IndexAsymptomatic DiseasesRisk Factors

Stichwörter der Autor:innen

Ankle-brachial indexCardiovascular risk equationsCarotid plaquesEcuaciones de riesgoEnfermedad vascular subclínicaMetabolic syndromePlacas carotídeasRiesgo vascularSubclinical vascular diseaseSíndrome metabólicoVascular riskÍndice tobillo-brazo

Autor:innen und Institutionen

  • Unidad de Lípidos y Riesgo Cardiovascular, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, España. Electronic address: josemaria.mostaza@salud.madrid.org.
  • Unidad de Lípidos y Riesgo Cardiovascular, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, España.
  • Gerencia Adjunta de Planificación y Calidad, Atención Primaria, Servicio Madrileño de Salud, Madrid, España.
  • Unidad de Día, Hospital La Paz-Carlos III, Madrid, España.

Förderung

  • Novo Nordisk Pharma Co Ltd

Zitieren

APA

Mostaza, J. M., Lahoz, C., Salinero-Fort, M. A., Estirado, E., García-Iglesias, F., González Alegre, T., Cornejo, V., & en representación de los investigadores del estudio ESPREDIA (2025). Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.106987

Vancouver

Mostaza JM, Lahoz C, Salinero-Fort MA, Estirado E, García-Iglesias F, González Alegre T, et al. Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico. Medicina Clínica. 2025. doi:10.1016/j.medcli.2025.106987

BibTeX
@article{Mostaza2025,
  author = {Mostaza, José María and Lahoz, Carlos and Salinero-Fort, Miguel A and Estirado, Eva and García-Iglesias, Francisca and González Alegre, Teresa and Cornejo, Víctor and en representación de los investigadores del estudio ESPREDIA, en representación de los investigadores del estudio ESPREDIA},
  title = {Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico},
  journal = {Medicina Clínica},
  year = {2025},
  doi = {10.1016/j.medcli.2025.106987}
}
Kostenlos starten →